The recent cancellation of a key FDA meeting on flu vaccine strains has raised alarms among health experts, who fear it could impact vaccine quality and availability. With flu season approaching, is the U.S. prepared to protect its citizens?
In a shocking move, the FDA has canceled a vital meeting on flu vaccine strains, raising concerns during one of the most severe flu seasons in over a decade. Expert Dr. Paul Offitt weighs in on the implications.
